CNS Pharmaceuticals CNSP
NASDAQ CNSP
$4.82 -0.16 (-3.31%)
As of: Oct 21, 2026 · 12:16 PM EDT

CNS Pharmaceuticals (CNSP) Receivables - Other (2021 - 2022)

Updated

CNS Pharmaceuticals' Receivables - Other came in at $393,182 for Q4 2022, down 40.1% from $656,938 a year earlier.

Analysis

CNS Pharmaceuticals (CNSP) Receivables - Other (2021 - 2022) Analysis & Trends

  • Going back by year, Receivables - Other was $656,938 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 CNS Pharmaceuticals 2.14 Mn -40.10 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 393,182.00
Dec 31, 2021 656,938.00
Jun 30, 2021 3.57 Mn
API Access

CNS Pharmaceuticals Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=CNSP&period=max&api_key=YOUR_API_KEY